{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=44&state=Washington", "query": { "state": "Washington", "city": "Seattle", "page": 44 }, "page_size": 10 }, "pagination": { "page": 44, "page_size": 10, "total_count": 2601, "total_pages": 261, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=45&state=Washington&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=43&state=Washington&page_size=10" }, "source": "local", "last_synced_at": "2026-11-04T02:20:56.361Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05416307", "title": "Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Secondary Hemophagocytic Lymphohistiocytosis (sHLH)" ], "interventions": [ { "name": "ELA026", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Electra Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 156, "start_date": "2022-05-19", "completion_date": "2030-03", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-15T00:15:19.889Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05416307" }, { "nct_id": "NCT04867317", "title": "Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Adult Growth Hormone Deficiency", "Mild Traumatic Brain Injury" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Somatropin", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "21 Years to 55 Years" }, "enrollment_count": 172, "start_date": "2025-01-13", "completion_date": "2029-09-30", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-14T12:01:35.969Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • San Diego, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04867317" }, { "nct_id": "NCT04302025", "title": "A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-small Cell Lung Cancer" ], "interventions": [ { "name": "Alectinib", "type": "DRUG" }, { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Chemotherapy", "type": "DRUG" }, { "name": "Cobimetinib", "type": "DRUG" }, { "name": "Divarasib", "type": "DRUG" }, { "name": "Entrectinib", "type": "DRUG" }, { "name": "Pralsetinib", "type": "DRUG" }, { "name": "Resection", "type": "PROCEDURE" }, { "name": "SBRT", "type": "DRUG" }, { "name": "Vemurafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 99, "start_date": "2020-11-06", "completion_date": "2030-05-30", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-14T19:05:17.386Z", "location_count": 38, "location_summary": "Duarte, California • Irvine, California • Los Angeles, California + 28 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04302025" }, { "nct_id": "NCT02071134", "title": "Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "Deep Brain Stimulation (DBS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1500, "start_date": "2014-03-04", "completion_date": "2038-12", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-30T13:09:54.777Z", "location_count": 29, "location_summary": "Aliso Viejo, California • Los Angeles, California • Aurora, Colorado + 25 more", "locations": [ { "city": "Aliso Viejo", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Grand Junction", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02071134" }, { "nct_id": "NCT01719055", "title": "RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pain" ], "interventions": [ { "name": "neurostimulation system", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4800, "start_date": "2012-11-19", "completion_date": "2035-05", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-19T20:58:00.804Z", "location_count": 67, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Campbell, California + 60 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Campbell", "state": "California" }, { "city": "Carlsbad", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01719055" }, { "nct_id": "NCT07206056", "title": "An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Progressive Metastatic Castrate Resistant Prostate Cancer" ], "interventions": [ { "name": "JSB462 Dose 1 QD", "type": "DRUG" }, { "name": "JSB462 Dose 2 QD", "type": "DRUG" }, { "name": "JSB462 QD", "type": "DRUG" }, { "name": "Standard of Care (SoC)", "type": "DRUG" }, { "name": "Tulmimetostat DL1 QD", "type": "DRUG" }, { "name": "Tulmimetostat DL2 QD", "type": "DRUG" }, { "name": "Tulmimetostat DL3 QD", "type": "DRUG" }, { "name": "Tulmimetostat Doses 1 or 2 QD", "type": "DRUG" }, { "name": "Tulmimetostat RP2D QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 188, "start_date": "2025-10-15", "completion_date": "2030-12-01", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-14T23:42:48.850Z", "location_count": 8, "location_summary": "Denver, Colorado • Jacksonville, Florida • Atlanta, Georgia + 5 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07206056" }, { "nct_id": "NCT07124078", "title": "A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Graft-versus-host-disease" ], "interventions": [ { "name": "Best available Treatment (BAT)", "type": "DRUG" }, { "name": "INCA034176", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 60, "start_date": "2026-05-20", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-16T10:14:08.175Z", "location_count": 11, "location_summary": "Duarte, California • Los Angeles, California • Palo Alto, California + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07124078" }, { "nct_id": "NCT07001332", "title": "ELEVATE High-Risk PCI Pivotal Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "High-Risk Percutaneous Coronary Intervention (High-risk PCI)" ], "interventions": [ { "name": "Elevate", "type": "DEVICE" }, { "name": "Impella", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Magenta Medical Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "88 Years", "sex": "ALL", "summary": "18 Years to 88 Years" }, "enrollment_count": 290, "start_date": "2025-07-25", "completion_date": "2027-09-16", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-16T00:11:47.220Z", "location_count": 33, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07001332" }, { "nct_id": "NCT06863272", "title": "A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Castration-Resistant Prostatic Cancer", "Metastasis" ], "interventions": [ { "name": "Abiraterone", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Ifinatamab Deruxtecan", "type": "DRUG" }, { "name": "Opevesostat", "type": "DRUG" }, { "name": "Rescue Medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 360, "start_date": "2025-07-03", "completion_date": "2031-10-01", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-11-04T02:20:56.361Z", "location_count": 9, "location_summary": "Los Angeles, California • Orange, California • San Francisco, California + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06863272" }, { "nct_id": "NCT06836232", "title": "An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Pericarditis" ], "interventions": [ { "name": "VTX2735", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zomagen Biosciences Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 50, "start_date": "2025-01-28", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-14T08:21:21.105Z", "location_count": 15, "location_summary": "La Jolla, California • Orange, California • Saint Augustine, Florida + 10 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Saint Augustine", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06836232" } ] }